Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Motavizumab, a Humanized, Enhanced-Potency Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus Infection in At-Risk Children
Abarca, Katia, Jung, Elizabeth, Fernández, Pilar, Zhao, Liang, Harris, Brian, Connor, Edward M., Losonsky, Genevieve A.Volume:
28
Language:
english
Journal:
The Pediatric Infectious Disease Journal
DOI:
10.1097/inf.0b013e31818ffd03
Date:
April, 2009
File:
PDF, 345 KB
english, 2009